Earnings Scorecard & Analyst Reports for NASDAQ:AZYO, NASDAQ:THCA, NASDAQ:MIST, NYSE:ALTG

AZIYO BIOLOGICS (NASDAQ:AZYO) EARNINGS INFORMATION (NASDAQ:AZYO)

Aziyo Biologics last announced its earnings results on August 8th, 2021. The reported ($0.58) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.53) by $0.05. Aziyo Biologics has generated ($8.88) earnings per share over the last year. Earnings for Aziyo Biologics are expected to grow in the coming year, from ($2.10) to ($1.55) per share. Aziyo Biologics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 18th, 2021 based off prior year’s report dates.

IS AZIYO BIOLOGICS A BUY RIGHT NOW? (NASDAQ:AZYO)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Aziyo Biologics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Aziyo Biologics stock.
Aziyo Biologics

TUSCAN HOLDINGS CORP. II EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:THCA)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN TUSCAN HOLDINGS CORP. II? (NASDAQ:THCA)

Wall Street analysts have given Tuscan Holdings Corp. II a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tuscan Holdings Corp. II wasn’t one of them. MarketBeat thinks these five companies may be even better buys.

MILESTONE PHARMACEUTICALS (NASDAQ:MIST) EARNINGS INFORMATION (NASDAQ:MIST)

Milestone Pharmaceuticals last posted its quarterly earnings data on August 11th, 2021. The reported $0.02 EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.28. Milestone Pharmaceuticals has generated ($1.70) earnings per share over the last year (($1.46) diluted earnings per share). Earnings for Milestone Pharmaceuticals are expected to decrease in the coming year, from ($1.34) to ($1.61) per share. Milestone Pharmaceuticals has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, November 12th, 2021 based off prior year’s report dates.

IS MILESTONE PHARMACEUTICALS A BUY RIGHT NOW? (NASDAQ:MIST)

1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Milestone Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should “buy” Milestone Pharmaceuticals stock.
Milestone Pharmaceuticals

ALTA EQUIPMENT GROUP (NYSE:ALTG) EARNINGS INFORMATION (NYSE:ALTG)

Alta Equipment Group last issued its earnings data on May 12th, 2021. The reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.13) by $0.06. The firm earned $268.80 million during the quarter, compared to the consensus estimate of $245.50 million. Alta Equipment Group has generated ($0.61) earnings per share over the last year (($0.41) diluted earnings per share). Earnings for Alta Equipment Group are expected to grow by 488.89% in the coming year, from $0.09 to $0.53 per share. Alta Equipment Group has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

IS ALTA EQUIPMENT GROUP A BUY RIGHT NOW? (NYSE:ALTG)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Alta Equipment Group in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Alta Equipment Group stock.
Alta Equipment Group